Several studies have evaluated the prognostic impact of the KRAS mutation in patients with CRC, investigating whether there was a difference in terms of prognosis compared to the type of KRAS mutation (G12C, G12V, G12D, G12A, and codon KRAS mutations 13) [26,27,28,29]. This evidence concerns the gene KRAS and colorectal carcinoma.